Timm Crowder, PhD - SVP, Technical Operations

Timm joined Spyryx in 2015 to lead inhaled product development, device selection and manufacturing and supply for Spyryx’s product candidates.  He came to the Company from GlaxoSmithKline where he was most recently Director of Advanced Manufacturing Technology, leading innovation in the areas of aerosol release testing, technology enhanced manufacturing strategies, electronic inhaler and particle engineering technologies.  Earlier in his GSK career he contributed to late-stage development of GSK’s current asthma and COPD products.  Prior to GSK, Timm was co-founder of Oriel Therapeutics, an inhaler technology company built around device designs he developed during his graduate research.  Oriel was subsequently acquired by Sandoz Pharmaceuticals. 

Timm earned his PhD in Biomedical Engineering from the University of North Carolina-Chapel Hill and has degrees in Physics from North Carolina State University and Davidson College.  He is an inventor on 10 issued patents on inhalers and powder filling systems and has 25 publications, book chapters and international presentations relating to aerosol drug delivery, inhaler design, powder filling, powder flow, formulation and product characterization.